Optometry News

Healio spoke with Bradley Dougherty, OD, PhD, associate professor at The Ohio State University College of Optometry, about how socioeconomic factors can affect the diagnosis, treatment and outcomes of age-related macular degeneration.

A questionnaire found that the majority of retina fellows planned to go into a retina-only private practice.

The progression of vision loss among patients with neovascular glaucoma appeared linked to factors such as the disease stage at diagnosis, age, sex, a history of type 2 diabetes and insurance status, according to study results.

Eclipse Life Sciences has enrolled and dosed the first patient in the BETTIS-1 phase 2 clinical trial investigating the EC-104 implant for the treatment of diabetic macular edema, according to a press release.

Eye6 with Ivy, a new wearable vision aid with an interactive AI visual assistant for individuals with age-related macular degeneration and other retinal disorders, is now available, according to a press release from Eyedaptic.

An AI program accurately identified posterior vitreous opacities in patients with posterior vitreous detachments, which may improve screening for retinal tears, according to a study.

The progression of myopia among school-aged children in China appeared to primarily affect changes in inner retinal thickness over the course of 1 year, according to research.

An AI model was able to identify several common eye diseases in children using cell phone photos that could be taken at home, researchers reported in JAMA Pediatrics.

The FDA approved the Enzeevu 2 mg vial kit and prefilled syringe for intravitreal injection for the treatment of neovascular age-related macular degeneration, according to a press release from Sandoz.

Eyenovia and SGN Nanopharma have announced a collaboration agreement to develop a new drug-device combination product for chronic dry eye disease.